Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00218582 · ClinicalTrials.gov registry record · Phase 1
Effectiveness of Self-Help for Dually-Diagnosed Persons - 1
A Phase 1 study, sponsored by National Institute on Drug Abuse (NIDA).
- Completed
- Registry status
- Phase 1
- Development phase
- 229
- Enrollment target
NCT00218582: Completed Phase 1 study, sponsored by National Institute on Drug Abuse (NIDA).
NCT00218582 is a Phase 1 study that has completed, run by National Institute on Drug Abuse (NIDA). The registered enrollment target is 229 participants, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (282% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00218582, a Phase 1 study, has completed, sponsored by National Institute on Drug Abuse (NIDA).
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 229 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the effectiveness of adding dual focus 12-step self-help groups to standard treatment to improve behavioral outcomes for patients dually diagnosed with substance abuse and psychiatric disorders.
Interventions
- BEHAVIORAL Double Trouble in Recovery
- BEHAVIORAL Standard psychiatric day treatment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 229 participants |
| Start Date | 2003-03 |
| Est. Completion | 2007-03 |
| Phase | Phase 1 |
What the finished NCT00218582 record still lists
NCT00218582 is an interventional study that assigns participants to a tested intervention. The registered 229 participants enrollment target is mid-sized for trials with a published cap, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (282% higher).
The record links to 0 conditions, and to 2 interventions - of which Double Trouble in Recovery is the first listed.
NCT00218582 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00218582 about?
NCT00218582 is a clinical study titled "Effectiveness of Self-Help for Dually-Diagnosed Persons - 1". The purpose of this study is to determine the effectiveness of adding dual focus 12-step self-help groups to standard treatment to improve behavioral outcomes for patients dually diagnosed with substance abuse and psychiatric disorders.
What is the current status of trial NCT00218582?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 229 participants. The study started on 2003-03. Estimated completion is 2007-03.
What interventions are being tested in trial NCT00218582?
The interventions under investigation include: Double Trouble in Recovery (BEHAVIORAL), Standard psychiatric day treatment (BEHAVIORAL).
Who is sponsoring clinical trial NCT00218582?
This trial is sponsored by National Institute on Drug Abuse (NIDA), which has 335 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00218582's enrollment target sits among peer trials
229 221st of 2000 higher than 1,780 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02710253 · 230 participants · Phase 2
Salvage Radiation Therapy in Treating Patients With Metastatic Cancer That Has Progressed After Systemic Immunotherapy
- NCT02777879 · 230 participants
Lung Microbiome and Inflammation in Early COPD
- NCT03824483 · 230 participants · Phase 2
Study of Zanubrutinib, Obinutuzumab, and Venetoclax in Patients With Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL)
- NCT03833622 · 230 participants · NA
Shared Decision Making to Improve Goals of Care in the ED
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia